Table 1.
Laboratory-confirmed influenza cases n (%) |
Influenza-negative controls n (%) |
p value | |
---|---|---|---|
Total | 542 (100) | 1219 (100) | |
Age groups (years) | 0.047 | ||
25–64 | 143 (26) | 261 (21) | |
65–84 | 313 (58) | 729 (60) | |
≥ 85 | 86 (16) | 229 (19) | |
Sex | 0.029 | ||
Male | 362 (67) | 877 (72) | |
Female | 180 (33) | 342 (28) | |
Healthcare setting | < 0.001 | ||
Primary healthcare | 92 (17) | 72 (6) | |
Hospital | 450 (83) | 1147 (94) | |
Other major chronic conditions | |||
Diabetes | 147 (27) | 395 (32) | 0.027 |
Cancer | 148 (27) | 367 (30) | 0.233 |
Liver cirrhosis | 34 (6) | 94 (8) | 0.283 |
Renal disease | 91 (17) | 228 (19) | 0.336 |
Immunodeficiency | 16 (3) | 32 (3) | 0.697 |
Asthma | 50 (9) | 90 (7) | 0.187 |
Cardiovascular disease | 180 (33) | 483 (40) | 0.010 |
Dementia | 10 (2) | 38 (3) | 0.130 |
Stroke | 38 (7) | 95 (8) | 0.566 |
Rheumatic disease | 19 (4) | 33 (3) | 0.361 |
Severe obesity | 25 (5) | 50 (4) | 0.624 |
Vaccination in the current season | < 0.001 | ||
No | 233 (43) | 387 (32) | |
Yes | 309 (57) | 832 (68) | |
Influenza vaccines in the 5 prior seasons | < 0.001 | ||
0 | 166 (31) | 251 (21) | |
1–2 | 69 (13) | 146 (12) | |
3–5 | 307 (56) | 822 (67) | |
Influenza season | < 0.001 | ||
2015–2016 | 80 (14) | 150 (12) | |
2016–2017 | 102 (19) | 181 (15) | |
2017–2018 | 161 (30) | 242 (20) | |
2018–2019 | 123 (23) | 288 (24) | |
2019–2020 | 76 (14) | 358 (29) |